BusinessGlobal CBD Market Yields Great Opportunities -- CFN MediaBy Nasdaq OMXJan 16, 2018, 5:34 PM UTC
BusinessEaston Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the CompanyBy Nasdaq OMXJan 10, 2018, 2:04 PM UTC
BusinessPeregrine Pharmaceuticals Announces Name Change to Avid Bioservices as Part of Transition to Dedicated Contract Development and Manufacturing Organization (CDMO)By Nasdaq OMXJan 5, 2018, 1:05 PM UTC
BusinessInspire and Antidote Launch End-to-End Clinical Trial Recruitment Solution to Accelerate Medical ResearchBy Nasdaq OMXJan 4, 2018, 12:00 PM UTC
BusinessLife Science Marketers Embrace HapYak Interactive Video Solution Targeting ISI Compliance and MoreBy Nasdaq OMXDec 19, 2017, 5:08 PM UTC
BusinessINVESTORS SAY EXECUTIVE PAY PACKAGES AT PHARMA MAY INCENTIVIZE DRUG PRICING RISKSBy Nasdaq OMXDec 13, 2017, 6:13 PM UTC
BusinessCTI Clinical Trial and Consulting Services Announces Acquisition of EurotrialsBy Nasdaq OMXDec 7, 2017, 8:00 PM UTC
BusinessUPDATE: Rich Pharmaceuticals Retains Experienced Contract Research Organization to Assist with Clinical TrialsBy Nasdaq OMXDec 5, 2017, 5:35 PM UTC
